Interpace Biosciences Inc. (IDXG) - Analysis

1.14000 USD

0.024

2.06%

Last update Dec 16, 3:57 PM EST

Market closed

Day range

1.14000

1.14000

1.18000

Previous close

1.16400

Open

1.18000

Access this stock data via API

Interpace Biosciences Inc.

1.14

0.02

2.06%

Analysis

Revenue estimate	Next year (Dec 2025)
Number of Analysts	0
Avg. estimate	0
Low estimate	0
High estimate	0
Last year sales	121.68M
Sales growth	—

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS trend	Next year (Dec 2025)
Current estimate	0
7 days ago	0
30 days ago	0
60 days ago	0
90 days ago	0

Access /eps_trend data via our API — starting from the Ultra plan.

EPS revisions	Next year (Dec 2025)
Up last 7 days	0
Up last 30 days	0
Down last 7 days	0
Down last 30 days	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Recommendation

Buy

100%

Buy

Access /recommendations data via our API — starting from the Ultra plan.

Analyst ratings

Firm	Date	Action
HC Wainwright & Co.	Nov 17, 2021	Downgrade
HC Wainwright & Co.	Apr 09, 2021	Maintains
HC Wainwright & Co.	Jan 25, 2021	Maintains
HC Wainwright & Co.	Nov 25, 2020	Maintains
H.C. Wainwright	Nov 25, 2020	Maintains
Janney Capital	Nov 25, 2020	Initiates
Oppenheimer	Nov 25, 2020	Maintains
HC Wainwright & Co.	Oct 22, 2020	Maintains
HC Wainwright & Co.	Jun 26, 2020	Maintains
H.C. Wainwright	Apr 23, 2020	Maintains
HC Wainwright & Co.	Apr 23, 2020	Maintains
Janney Capital	Apr 15, 2020	Initiates
Janney Montgomery Scott	Apr 15, 2020	Initiates
Oppenheimer	Jan 16, 2020	Maintains

Access /analyst_ratings/light data via our API — starting from the Ultra plan.